Boenning & Scattergood’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$526K Sell
2,197
-1,504
-41% -$476K 0.08% 244
2022
Q3
$1.03M Buy
3,701
+1,502
+68% +$423K 0.21% 124
2022
Q2
$579K Buy
2,199
+2
+0.1% +$515 0.11% 202
2022
Q1
$526K Buy
2,197
+20
+0.9% +$4.68K 0.08% 244
2021
Q4
$500K Buy
2,177
+2
+0.1% +$425 0.08% 248
2021
Q3
$435K Buy
2,175
+2
+0.1% +$435 0.08% 258
2021
Q2
$515K Buy
2,173
+1
+0% +$250 0.09% 238
2021
Q1
$525K Sell
2,172
-16
-0.7% -$3.57K 0.1% 227
2020
Q4
$456K Hold
2,188
0.1% 217
2020
Q3
$371K Hold
2,188
0.09% 222
2020
Q2
$411K Sell
2,188
-100
-4% -$19K 0.11% 197
2020
Q1
$405K Buy
2,288
+18
+0.8% +$3.49K 0.14% 171
2019
Q4
$464K Buy
2,270
+200
+10% +$36.7K 0.12% 192
2019
Q3
$314K Sell
2,070
-300
-13% -$48.8K 0.09% 216
2019
Q2
$373K Buy
2,370
+600
+34% +$94K 0.11% 201
2019
Q1
$285K Buy
1,770
+220
+14% +$40.2K 0.09% 230
2018
Q4
$294K Buy
1,550
+150
+11% +$31.3K 0.1% 210
2018
Q3
$292K Hold
1,400
0.09% 216
2018
Q2
$238K Buy
+1,400
New +$242K 0.08% 248

Other funds holding CI

Boenning & Scattergood's CI Position: Q4 2022 in Review

Boenning & Scattergood reduced its Cigna (CI) stake by 41% in Q4 2022, selling an estimated $476K and leaving 2,197 shares worth $526K. The position accounts for 0.08% of the portfolio, ranked #244.

Boenning & Scattergood first reported a position in CI in Q2 2018 and has held it in 19 quarters since. The position peaked at $1.03M in Q3 2022. 1,558 funds tracked by Wall St. Rank hold CI as of Q4 2022.

  • Boenning & Scattergood held 2,197 shares of Cigna worth $526K as of Q4 2022.
  • Boenning & Scattergood sold 1,504 Cigna shares in Q4 2022, an estimated $476K.
  • Cigna made up 0.08% of Boenning & Scattergood's portfolio in Q4 2022, its #244 holding.
  • Boenning & Scattergood first reported a position in Cigna in Q2 2018 and has held it in 19 quarters since.
  • Boenning & Scattergood's Cigna position peaked at $1.03M in Q3 2022.
  • 1,558 funds tracked by Wall St. Rank held Cigna as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.